Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Prostate cancer: A challenge for screening. Surg Oncol Clin N Am 1999 Oct;8(4):693-702, vii

Date

08/24/1999

Pubmed ID

10452935

DOI

10.1016/s1055-3207(18)30183-2

Scopus ID

2-s2.0-0032883169 (requires institutional sign-in at Scopus site)   3 Citations

Abstract

Prostate cancer is the second leading cause of cancer related death in men over the age of 50 in the United States today. The serum prostate specific antigen has the highest predictive value of any diagnostic test for prostate cancer. Highly screened communities have realized an impressive downward stage migration, younger average age at detection, and an improved five-year survival rate. These improvements are necessary components for any successful screening program.

Author List

Donnell RF

Author

Robert F. Donnell MD Emeritus Associate Professor in the Urology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Age Factors
Humans
Male
Mass Screening
Middle Aged
Neoplasm Staging
Predictive Value of Tests
Prostate-Specific Antigen
Prostatic Neoplasms
SEER Program
Survival Rate